$QNRX +40% PREMARKET 🚀 🔹 Big rebound move as rare-disease biotech momentum heats up 📈 🔹 Quoin is developing treatments for rare skin diseases, led by QRX003

$QNRX +40% PREMARKET 🚀 🔹 Big rebound move as rare-disease biotech momentum heats up 📈 🔹 Quoin is developing treatments for rare skin diseases, led by QRX003 for Netherton Syndrome 🧬 🔹 Fresh catalyst: FDA conditionally approved QYLEKI™ as the proposed brand name for QRX003 🔥 🔹 QRX003 already …